Skip to main content
Clinical Trials/NCT04426253
NCT04426253
Unknown
Not Applicable

Identification of Genetic Factors Determining Disease Course and Preparation of Pharmacogenetic Applications in the New Type of Coronavirus Infection, COVID-19

Szeged University14 sites in 1 country1,000 target enrollmentJune 5, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Szeged University
Enrollment
1000
Locations
14
Primary Endpoint
Identification of genetic factors determining the course of the disease in case of COVID-19
Last Updated
5 years ago

Overview

Brief Summary

The study aims to identify environmental factors and genetic (gene mutation and gene expression) changes, which influencing the course of the disease the new type of coronavirus infection COVID-19 in patients nationwide in a multicenter study.

At first in the study will be performed 200 patients, selected for a homogeneous groups on the basis of the patient's anamnestic data, genetic testing.

Following the interim analysis, based on the results, another 800 people are planned to involve.

Registry
clinicaltrials.gov
Start Date
June 5, 2020
End Date
July 31, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Szeged University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • confirmed covid 19 infection

Exclusion Criteria

  • informed refusal

Outcomes

Primary Outcomes

Identification of genetic factors determining the course of the disease in case of COVID-19

Time Frame: 2020. December

Exploring genotype-phenotype connections based on anamnestic data of patients and joint bioinformatics analysis of its genetic variants

Study Sites (14)

Loading locations...

Similar Trials